A question that is bugging me for some time is the following:
Looking at some of the research results regarding the efficacy of LE supplements, it seems that a meta-level conclusion could be that in general LE supplements are more effective in lower life-forms as compared to mammals. A good example of this is the current state of research on resveratrol.
It seems to me that lower life-forms are more susceptible to the benefits of supplementation due to the fact that they do not have complicated metabolic structures or pathways. This allows the supplements to be
- better bio available;
- more effective due to the lack of clever biological feed-back loops
in lower life forms.
Since all mammals do have a certain level of “infection” with parasites such as bacteria, protozoa, molds and other unpleasant members of our biological environment, there must exist some sort of delicate balance:
- parasites are more susceptible to LE supplements;
- defence mechanisms against parasites of mammal host are improved by supplement intake.
How do we know that this balance comes out favourable for the host individual taking the supplements? Another factor is that (I assume) research is carried out under extremely hygienic circumstances, so that the level of parasitic infection of the research subjects is low as compared to real-life circumstances.
Please share your thoughts and facts you are aware of.